Zenith Drugs Limited — Others, 27-03-2025: Trading Window

Zenith Drugs Limited has announced a board meeting to declare the financial results for the quarter and half-year ending March 31, 2025. In preparation, the trading window for all connected persons and insiders will be closed from April 1, 2025, until 48 hours post-announcement of these results. This closure is standard practice to ensure compliance with insider trading regulations. Investors might view this move as a precautionary measure, signaling the company’s commitment to governance and transparency, which could enhance confidence but may also introduce temporary trading restrictions.